ABSTRACT
INTRODUCTION
Diabetes mellitus (DM) is a chronic metabolic disorder and is becoming a global health concern because of the increase in its prevalence. However, hyperglycemia and hyperlipidemia are some of the factors indicating this metabolic syndrome [1] . Hyperglycemia is a condition in which an excessive amount of glucose circulates in the blood plasma. Diabetic neuropathy may be a result of long-term hyperglycemia. Hyperlipidemia is characterized by abnormal elevation in plasma triglyceride, cholesterol and low density lipoprotein-cholesterol (LDL-c) and very low lipoprotein -cholesterol (VLDL-c) and has also been reported to be the most prevalent indicator for susceptibility to atherosclerotic heart disease [2] . Also, high blood glucose levels are associated with low level of high-density lipoprotein cholesterol (HDL-c) and increase of LDL-c cholesterol, thus increasing risk of coronary heart diseases. Therefore, it is vital to manage both diabetes and lipid levels [3] .
The increase in demand for cheaper therapeutics with no/minimum side effects is stimulating interest in studying the use of natural products for the treatment and management of diseases [4] . The medicinal values of these plants are usually due to the presence of phytochemicals [5] .
P. guineense belongs to the family Piperaceae commonly known as West African Black Pepper. It is a climbing plant climbing up to 12m high by its adventitious rootlets. It is known with different vernacular names in Nigeria which include 'Uziza' in Igbo, and 'Iyere' in Yoruba. The seeds are smooth and are prolate-elliptically shaped. The seeds, leaves and sometimes the stems are used in preparing soup. It imparts "heat" and a spicy pungent aroma to food. The plant is utilized for a variety of purposes which include human dietaries, preservative, bio-control agent as well as traditional medicine [6] .
Previous phytochemical studies of P. guineense seed extract revealed the presence of various substances such as alkaloids, flavonoids, tannins triterpenoids, cardiac glycosides and saponins [7] . Pharmacological and physiological studies of P. guineense extract showed depolarizing neuromuscular blocking action, insecticidal properties, sexual behavioural effect and antifungal activity [8] and edema in gastrointestinal tract, urinary bladder and adrenal glands and immunotoxicological effects [9] .
Aframomum melegueta K. Schum belongs to the ginger family (Zingiberaceae) and it is commonly known as grains of paradise or alligator pepper [10] . It is variously known locally as oseoji in Igbo, ataareinYoruba, and cittáá in Hausa of Nigeria. The seeds of A. melegueta have been variously reported to be rich in carbohydrates, crude fibre, and bulk minerals [11] suggesting it to be of good nutritional quality, and hence justifying its incorporation into diet. The report of [12, 13] , NMR and GC-MS analyses of the chloroform extract of the seeds and essential oils from various plant parts, respectively show the plant to be rich in secondary metabolites such as modified gingerols, paradols and shogaols. These metabolites account for some of peppery taste of the seeds [14] . The use of A. melegueta in traditional medicine in treating diabetes has been age long. The essential oils, polyphenol profile and antioxidant activity of Aframomum melegueta, have been reported [15, 16, 17, 18, 19] . It is used medicinally to treat many diseases including measles, leprosy; tostop lactation and post-partum haemorrhage, as antidiarrhea and anti-inflammatory activity which may be due to prostaglandin inhibition, and membrane stabilizing activity respectively [20] .
Many studies have been carried out on the seeds of these plants but there is dearth of scientific information on the leaves of these plants. Hence, this study investigated the antihyperglycemia and the anti-hyperlipidemic effects of the leaf extracts of A. melegueta and P. guineense.
MATERIALS AND METHODS

Chemicals
All chemicals and drugs used were obtained commercially and of analytical grade.
Collection of plant materials
The leaves of A. melegueta and P. Guineense were collected in February, 2015 at Okuku, OdoOtin local government, Osun State, Nigeria. It was identified and authenticated at IFE herbarium (17525), ObafemiAwolowo University, Ile-Ife.
The methanolic extracts of A. melegueta and P. guineense were separately prepared. The leaves were dried under shade and ground into powder. Typically, the powder (200g) was macerated in 2.5 L methanol (70%) at room temperature for 72h. It was then filtered using muslin cloth. The filtrates were allowed to settle, decanted and filtered using filtration assembly. The filtrates were evaporated using rotary evaporator and then freeze dried using lypholizer. The extracts were stored in air tight container in a refrigerator until used.
Acute toxicity study
The acute toxicity study was carried out using the Lorke's method [21] . The study was conducted using a total of twelve mice. The mice (12) weighing betwwen 30-34g were divided into 2 groups of 6 mice each. Groups 1 and 2 animals were given a single dose of 5000 mg/kg body weight (b.w.) of the A. melegueta and P. guineense extract respectively. The animals were observed for any toxic effect or mortality for 72 h after the treatment period.
Experimental Animals
Adult female and male albino rats (42) weighing between 120-150 g were obtained from the Animal House, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife. The rats were housed in polyethylene cages at the Animal House, Department of Biochemistry, Adeleke University, Ede and were kept under standard conditions; food and water were supplied ad libitum. They were allowed to acclaimatized for a period of 14 days.
Grouping and Treatment of Animals
The rats were randomly assigned into seven groups of six rats in each group as follows: The extracts and the reference drug (Glibenclamide) were administered orally.
Induction of Diabetes and Treatment with the Extracts
The animals were allowed to fast overnight and diabetes was induced by a single intra-peritoneal injection of alloxan monohydrate (150 mg/kg bwt). Increase glucose level was monitored 3 days after injection by measuring the tail vein blood glucose level using glucometer. The induced rats were orally treated with the extracts for 7 days.
Determination of Blood Glucose Levels
The level of blood glucose was determined according to the method described by [22] before and after treatment with the extract and standard drug by using a glucometer. The rats were subjected to fasting for 12-18 h with free access to water prior to the administration of the extract and the blood glucose level was measured. After the last treatment with the extracts, the animals were fasted overnight and the blood samples were collected for the determination of the blood glucose concentration.
Sacrificing and Preparation of Blood Plasma
The rats were sacrificed under mild anesthesia with ether, 24 h after the last treatment (oral administration of extracts and drug). Blood was collected by cardiac puncture into bottles containing anticoagulant (trisodium citrate, 3.8% w/v) and mixed gently. Blood plasma was prepared using standard procedure as reported and modified by Bode and Oyedapo [23] . Blood sample was centrifuged on Bench Centrifuge Model 90-2 (Searchtech Instrument England, UK.) at3000 rpm for 10 min. The supernatant (plasma) was collected into sterile bottles, labeled and stored in freezer for biochemical analyses.
Estimation of Plasma Lipid Profiles
Plasma lipid profiles: triacylglycerol (TG), total cholesterol (TC), High density lipoprotein cholesterol (HDL-c), low density lipoprotein cholesterol (LDL-c), were estimated spectrophotometrically using Randox assay kits.
Statistical Analysis
The data were statistically analyzed using t-test and ANOVA with the aid of SARS software package. The level of statistical significance was also compared using Duncan's multiple range test p < 0.05.
RESULTS
Yield of the Extract
The methanol leaf extract obtained from 500g of powdered leaf weighed 5.6g which was 1.12% of the starting material.
The methanol leaf extract obtained from 500g of powdered leaf weighed 97.69g which was 19.5% of the starting material.
Acute toxicity
The acute toxic effect of methanolic extracts of A. melegueta and P.guineense was determined using the Lorke's method [21] . There was no related toxic symptom or mortality observed after oral administration of the tested plant extracts at a dose of 5000 mg/kg. The general behavioral of the extract treated mice was observed first for short period (4 h) followed by long period (72 h), did not display any drug related changes in behavior, breathing, skin effects, water consumption, impairment in food intake. Therefore, the extract seems to be safe at a dose level of 5000 mg/kg.
Blood Glucose Level
In Table 1 is the summary of the initial and final concentrations of blood glucose. After induction of hyperglycemia with alloxan monohydrate, there was a significant increase (P<0.05) in blood glucose level of other experimental groups when compared with the normal control group. After treatment the extracts at 200 mg/kg and 400 mg/kg, the blood glucose level was significantly reduced (P<0.05) when compared to the alloxan treated rats. This indicated the antihyperglycemic potentials of the extracts. Table 2 is the summary of the effect of the extracts on the plasma lipid profile of alloxaninduced hyperglycemia rats. There was significant increase in the concentrations of TC, TG and LDL-c but adecrease in HDL-c of the alloxan treated group when compared to the control group. However, treatment with the extracts at 200 and 400 mg/kg bwt caused a significant reduction in the concentrations of TC, TG and LDL-c but an increase in HDL-c. 
Lipid Profiles
Values are mean ± SEM of six determinations. (n=6), Superscripts a,b and c represent significant (p<0.05) differences between treatment groups (IV, V, VI, VI) and control (I), Alloxan (II) and Alloxan+ Glibeclamide (III) respectively, Key: I-control, II -Alloxan, III -Alloxan + Glibeclamide (5mg/kg), IV -Alloxan + PG (200mg/kg bwt), V -Alloxan+ PG (400mg/kg bwt), VI -Alloxan+ AM (200mg/kg bwt), VII -Alloxan + AM (400mg/kg bwt)
DISCUSSION
The study evaluated anti-hyperglycemia and antihyperlipidemic effects of A. melegueta and P. guineense leaf extracts at 200 mg/kg bwt and 400 mg/kg bwt.The dose was chosen based on the reports of previous studies [24, 25, 26] . After the administration of alloxan monohydrate, there was significant increase (p < 0.05)in the blood glucose level of the alloxan-treatedgroup when compared to the normal control group (Table  2 ).Elevated value of fasting blood glucose concentration observed in alloxan treated rats may be due to the toxic effect of alloxan on islet beta cells of the pancreas through its ability to induce reactive oxygen species (ROS) formation, resulting in the necrosis of the pancreas and loss of capacity of the pancreas to secrete insulin resulting to hyperglycemia [27, 28, 29] .
Chronic exposure to hyperglycemia is the primary casual factor in the pathogenesis of diabetic complications and cause changes in vascular tissue which promote atherosclerosis [30] . Our findings is in agreement with the report of earlier studies that administration of alloxan at the dose of 250mg/kg was able to increase to elevate the fasting blood sugar levels [31, 32] . However, post-treatments with P. guineense and A. melegueta at 200 mg/kg and 400 mg/ kg bwt extracts were able to significantly lower the blood glucose respectively when compared to the alloxan treated group.
Both extracts compared favorably with the reference drug, Glibenclamide and the highest effect was observed in A. melegueta at 200 mg/kg bwt. The observed anti-hyperglycemia activity of these extracts may be attributed to the presence of phytochemicals such as: total phenols, flavonoids, alkaloids,tannins, terpenoids, and saponins in the plants that have been known to have anti-hyperglycemic activity [31] . The presence of these bioactive compounds was earlier reported by our previous studies [10, 32] . Studies also reported that flavonoids have anti-hyperglycemic properties because they stimulate glucose uptake in peripheral tissues and attenuate oxidative stress during diabetic conditions [33, 34] . Flavanoids have been reported to be actively involved in the restoration of pancreatic β-cell and insulin secretion. A large number of alkaloids have been isolated from numerous medicinal plants and investigated for their possible anti-hyperglycemic activity [35] . Saponins are known to be efficiently involved in the restoration of pancreatic β-cell and insulin secretion [33, 36] .
One of the associated metabolic disorders of diabetes is dyslipidemia which is one of the risk factors of diabetes [37] . Hypercholesterolemia and hypertriglyceridemia have been reported to occur in alloxan treated rats [38, 39] . The elevated values for lipid profile: TC, TG, LDLcholesterol, observed in the alloxan induced diabetic rats could be partly due to increased intestinal biosynthesis of cholesterol because diabetes shifted the major site of cholesterogenesis from the liver to the small intestine leading to hypercholesterolemia [40] . Severe diabetes mellitus due to insulin deficiency might be accompanied with a reduced LDLreceptor resulting to high concentration of serum LDL cholesterol in diabetic subjects [41] .
The results of the extracts treated groups revealed a significant reduction in the levels of total cholesterol, triglyceride, LDL but an increase in HDL when compared to the alloxantreated group. The anti-hyperlipidemic effect was more apparent in the A. melegueta treated group at 200 and 400 mg/kg bwt. This revealed the anti-hyperlipidemic activity of the plant extracts. The ability of A. melegueta and P. guineense to ameliorate the lipid profile may be attributed to the presence of phytochemicals in the plants. Epidemiological studies have shown that bioactive compounds such as flavonoids intake are inversely related to mortality from coronary heart diseases and the incidence of heart attacks [42].
CONCLUSION
In conclusion, the results of this study revealed that the plant extracts elicited anti-hyperglycemic effect and normalized the lipid profile of diabetic rats. This study showed that these spices do not just impact flavour to foods, but may be sources of bioactive substances useful in the treatment and management of diabetes and related disorders.
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